https://www.selleckchem.com/pr....oducts/bos172722.htm
.7% seizure termination (N = 12) and severe neuropathology (22.0 ± 1.8, N = 5). While ENBA and CCPA both demonstrate a clear ability to terminate SE when administered up to 60 min after seizure onset, ENBA offers more neuroprotection, making it a promising candidate for NA-induced SE.The brain vasculature has several specific features, one of them being the blood-brain barrier (BB, which supports and protects the brain by allowing for the passage of oxygen and nutrients, while at the same time preventing passage of pathogens and tox
Like
Comment
Share
